1. Medtech Insight
  3. >>Legislation

Budget Accord Should Increase FDA Funding, Free Up User Fees

The deal, which sets total FY 2014 discretionary spending at $1.012 trillion, leaves specific appropriations up to congressional committees and frees up user fees from sequestration for two years, both positive developments for FDA’s financial health. Device groups also tout a non-binding provision to repeal the device tax.

The two-year budget deal

that passed the House and awaits consideration by the Senate will have a positive financial impact on FDA, and incorporates non-binding language favoring device tax repeal.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation